News and Events


Our Researchers in the News

Kathy McCoy

UCalgary researchers discover the microbiome’s role in attacking cancerous tumours

Findings show how our gut bacteria can enhance immunotherapy to battle different forms of cancer

Researchers with the Snyder Institute for Chronic Diseases at the Cumming School of Medicine (CSM) have discovered which gut bacteria help our immune system battle cancerous tumours and how they do it. The discovery may provide a new understanding of why immunotherapy, a treatment for cancer that helps amplify the body’s immune response, works in some cases, but not others.

View Article 

Sean Thompson

The interconnectivity of the world has never been more apparent to us than during a pandemic. Tapping into our natural need to connect with one another is a logical first step to solving some of our biggest global issues.

One of these global issues is the containment of antimicrobial resistance (AMR) which, according to the World Health Organization (WHO), is when “microorganisms (such as bacteria, fungi, viruses, and parasites) change when they are exposed to antimicrobial drugs (such as antibiotics, antifungals, antivirals, antimalarials, and anthelmintics).” When this change occurs, these microorganisms, which are often referred to as ‘Superbugs’ develop AMR, which results in the medicines becoming ineffective.

Check out page 23 of the new edition of Horizons, Olds College Newsletter, on "Health Impacts of Optimized Pre-conditioning in Beef Cattle” story, one of the AMR - One Health Consortium projects, chaired by Principal Investigator Dr. Karin Orsel from the University of Calgary, and Co-Investigator, Sean Thompson, Manager, Technology Access Centre (TAC) for Livestock Production, from the Olds College.

View Newsletter
 

Ellen Goddard

Five ways COVID-19 will change the food business

Eating at home more and sticking with online delivery or takeout are habits likely to persist even as pandemic measures ease, according to one expert.

“The ‘new normal’ is unlikely to be the same for retail and food service as life was in January of 2020,” when the first case of COVID-19 was reported in Canada, said Ellen Goddard, one of the AMR - One Health Consortium Principal Investigators and the University of Alberta food economist.

View Article

Kathy McCoy

The Quirks & Quarks listener show with Kathy McCoy

Kathy McCoy, UofC professor, director of the International Microbiome Centre and Consortium Principal Investigator, was featured on the June 27th episode of The Quirks and Quarks listener show. Kathy discussed how the microbiome of a pregnant woman affects the developing fetus.

Listen to the full episode

Marie

Fungi play a critical role within our gut microbiome, research finds

Many fundamental scientific questions about the relationships between microbiomes and their hosts are unanswered. We know that bacteria in the microbiome are critical but there is little known about the role of fungi. Fungi have prominent roles in soil, marine, plant, and even food microbiomes. But what about the gut? Do gut fungi directly impact the microbiome, gut physiology and human immunity? 

A recent study by Dr. Marie Claire Arrieta, PhD, assistant professor at the University of Calgary’s Cumming School of Medicine (CSM), and Co-principal Investigator with the AMR-One Health Consortium, shows that fungi have a larger role in the development of the gut microbiome than we realized. 

View Article 

Ian

Leading metabolomics researcher in Faculty of Science mobilizes lab to help with COVID-19 relief

Dr. Ian Lewis, one of the AMR-One Heath Consortium Co-Investigators, has devoted his career to developing faster, more efficient ways to diagnose infections. Now, during the COVID-19 global pandemic, he and his collaborators are ready to face an unprecedented challenge as his field of research is being thrust into the spotlight.

View Article

null

Premier Kenney says he might bring in tests and vaccines for COVID-19 not yet approved

Ryan Jespersen talks news, politics, and pop culture. He's one of Alberta’s 50 Most Influential People and one of Edmonton’s Top 40 Under 40 on Avenue Magazine’s inaugural list, Ryan has established himself as a next-generation mover and shaker in Alberta’s capital city.


Check out Ryan's recent discussion with Dr. Lorian Hardcastle, assistant professor, faculty of law, University of Calgary, and one of the AMR-One Health Consortium Principal Investigators on Premier Kenney's recent announcement saying "he might bring in tests and vaccines for COVID-19 not yet approved by Health Canada"

Listen to Podcast

 

null

The Effects of COVID-19 on the Health System: Legal and Ethical Tensions Part II

Since it appeared in Canada at the end of January, the number of cases of COVID-19 has steadily increased. Despite considerable efforts to contain the spread of the disease, Canada has seen over 1000 new cases per day since late March, with this number reaching 1600 new cases in a single day on April 5. On April 7, 58 people succumbed to the disease in one day. The ongoing COVID-19 outbreak raises numerous pressing legal and ethical tensions. 

View Article

 

null

UCalgary researchers tapped to help mitigate spread of coronavirus

Three University of Calgary-led research teams including Dr. Dylan Pillai and Dr. Myles Leslie, AMR – One Health Consortium Principal Investigators have received over $1.6 million in federal funding to accelerate the development, testing and implementation of countermeasures to mitigate the rapid spread of COVID-19, and its consequences on people and communities.

View Article

Ebola

Drug meant for Ebola may also work against coronaviruses

A group of University of Alberta researchers who have discovered why the drug remdesivir is effective in treating the coronaviruses that cause Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS) expect it might also be effective for treating patients infected with the new COVID-19 strain. “Even if you know a drug works, it can be a red flag if you don’t know how it works,” said virologist Matthias Götte, one the AMR – One Health Consortium Principal Investigators.

View Article

null

Coronavirus outbreak raises ethical dilemmas for governments and health-care systems

From the restriction of fundamental liberties to the rationing of scarce medical resources, the spread of COVID-19 is expected to raise extraordinary ethical dilemmas for leaders in government and the health-care system.

Check out what Lorian Hardcastle, a professor in the faculties of law and medicine at the University of Calgary, and one of the AMR – One Health Consortium Principal Investigators had to say in this regard:

View Article

Corona Virus hospital

Why doctors find fighting the coronavirus so challenging

Canadian infectious disease specialist Dr. John Conly says scientists don't yet understand the virus's transmission.

February, 2020

View Article

null

Who are you? Event guests take a quiz to learn more about their microbiomes

UCalgary expertise featured at Canadian Museum of Nature in Ottawa

February, 2020 

View Article 

 

Kathy

On-demand talk – Our lifestyles, our microbes: The hidden connection

In this sold-out talk at the Canadian Museum of Nature in Ottawa, Dr. Kathy McCoy, one of the Principal Investigators of the AMR-One Heath Consortium from the Cumming School of Medicine, University of Calgary, discusses the effect of modern lifestyles on the human gut.

January, 2020 

Watch Talk

null

How our relationships and our environments change our microbiomes?

Do our guts reflect the people around us? How our relationships and our environments change our microbiomes?

Check out this article from Laura Sycuro, AMR researcher from the University of Calgary, and learn how our microbiomes are affected by our places, our pets and our people.

December, 2019

View Article

null

Superbug Killers

Check out Jon Dennis, AMR researcher from the University of Alberta and his lab who have recently been featured in a CTY W5 piece called "Superbug Killers".

December, 2019

View Article

null

The problem of antimicrobial resistant bacteria has become a serious threat to all of us.

Listen to freelance broadcaster Don Hill talk with AMR researchers, John Conly from the University of Calgary and Ellen Goddard at the University of Alberta about the problem of AMR and the report’s findings.

November 2019

View Article 


AMR in the News

null

AVMA Report Details Antimicrobial Resistance Impact In Cattle

August 26, 2020

Research results enabled the scientists to develop an easy-to-reference, host-specific summary detailing pathogens of concern for cattle, followed by details about each pathogen and its resistance profile. ( AVMA )

View Article

AMR

World Health Organization

Record number of countries contribute data revealing disturbing rates of antimicrobial resistance

Geneva—A record number of countries are now monitoring and reporting on antibiotic resistance - marking a major step forward in the global fight against drug resistance. But the data they provide reveals that a worrying number of bacterial infections are increasingly resistant to the medicines at hand to treat them.

Read Article

null

The Pew Charitable Trusts: 

Tracking the Global Pipeline of Antibiotics in Development

The most recent assessment of the Global Pipeline shows that there are 41 new antibiotics in development. These drugs would potentially address many, but not all, resistant bacteria. However, given the inevitability that some of these antibiotics will fail to win approval, and that resistance will eventually develop to those that are approved, it is clear that there are too few drugs in development to meet current and anticipated patient needs.

Read Article 

null

Livestock Gentec

Solving AMR through a One-Health lens

The newly-funded Antimicrobial Resistance – One Health Consortium managed out of Ucalgary* is about to play an important role in how we safeguard the eroding ability of antibiotics to save lives and prevent illness. Its role will be to leverage the capacity and expertise across Alberta, nationally and internationally to find solutions to a looming antimicrobial resistance (AMR) crisis in humans and animals that spills over to the environment—hence the one health approach. Currently, several thousand Canadians die every year from infections with multiple drug-resistant bacteria, and the rate of increase is exponential. Worldwide, the economic impact of these infections is estimated at US$100 trillion/year.

Check out the Livestock Gentec interview with Dr. Herman Barkema, Scientific Director of the AMR – One Health Consortium in this regard:

See Interview

null

National Post

More deaths, fewer joint replacements, huge costs: The superbug crisis is already here, report warns

According to an expert panel report, 26% of bacterial infections are now resistant to the drugs normally used to treat them, a rate predicted to reach 40%According to an expert panel report, 26% of bacterial infections are now resistant to the drugs normally used to treat them, a rate predicted to reach 40%

Read Article 

null

Global News

Drug-resistant ‘superbugs’ could take a heavy toll on Canadians if not tackled head-on: Winnipeg researcher

Up to 400,000 Canadians could die over the next three decades if the country top doctors don't work on combating drug-resistant 'superbugs', says a new report.

Read Article 

CTV News

Professor urges conservation and innovation to stop antibiotic-resistant superbugs

In the wake of a new report that predicts the deaths of nearly 400,000 Canadians in the next 30 years to antibiotic-resistant superbugs, a Canadian academic is urging the government and pharmaceutical companies to do more.

Read Article 

null

CTV W5

A long forgotten Canadian discovery used to treat superbugs

A cystic fibrosis patient infected with a dangerous superbug has become one of the first Canadians to try phage therapy -- inhaling viruses found in sewage to kill the bacteria in her lungs. The experimental treatment, discovered in Canada over a century ago, may become a new weapon in the war against drug resistant bacteria.

Read Article

null

Gazette - Memorial University of Newfoundland

A role for everyone

It’s no secret that Newfoundland and Labrador is the best of the worst when it comes to antibiotic prescribing in Canada. Prescribing rates in the province are much higher than the national average, and those rates pose a considerable public health risk. Overuse of antibiotics leads to the development of resistant bacteria, which can mean …

Read Article

null

Financial Post

How a Winnipeg entrepreneur is using Mother Nature’s deadly weapon to fight antibiotic-resistant superbugs

One to watch: Steven Theriault’s research on bacteriophages has put him at the cutting edge of a potential bio-medical revolution

Read Article 


Member Recognition

null

John Conly invested into Order of Canada

May 14, 2019

Pioneer in antimicrobial resistance, infection prevention and health-care innovation receives honour

View Article


Events

Upcoming Events

null

One Health Antimicrobial Stewardship Conference

Nov. 19 - 20, Edmonton, Alberta

Postponed

Virtual Conference to be held 2021

The ABVMA is postponing the One Health Antimicrobial Stewardship Conference originally scheduled for Nov 19-20, 2020. The conference will now be offered virtually in spring 2021 (dates TBD).

Updates can be found at: www.ohab.ca/one-health-2020/.

null

AMR – One Health Consortium Annual Retreat

Nov. 25 - 27, Banff, Alberta

Postponed

Due to the current COVID-19 pandemic, the 2nd Annual Retreat, originally planned for Nov 25-27, 2020 in Banff, will now be delivered in a new virtual format. The Consortium, in collaboration with One Health at UCalgary, Alberta Veterinary Medical Association and Genome Alberta will be hosting a multidisciplinary, cross-sectoral workshop series around issues that are threatening human, animal, and environmental health, and the sustainability of Alberta's livestock industry. The workshop series will be open to public and bring together stakeholders from private sector, academia, and government for presentations and panel discussions.

Stay tuned for more information!
 


Past Events

null

One Health at UCalgary Seminar: Animals & COVID-19

What are the risks of COVID-19 transmission to animal? How should you protect your pet and yourself from COVID-19? How does it move between species? 

One Health at UCalgary held a conversation webinar about Animals and COVID-19 on May 27, 2020. 

Craig Jenne (Infectious Disease Specialist), Doug Whiteside (Zoo Veterinarian) and Rebecca Archer (Companion Animal Veterinarian) came together to discuss what we know about animals and COVID-19, how we can mitigate the risk to animals, and help us to understand the risk of transmission between animals and people.

Check out the recorded session via Zoom link - Password: 2E@5?657

 

null

AMR – One Health Consortium First Annual Retreat

The AMR – One Health Consortium first annual retreat was held on Oct 10-11, 2019, in Banff with more than 100 attendees. 

This retreat was aimed at connecting Consortium team members within and across work packages, facilitating networking, and determining ways to best to align/collaborate in the future.

Work Package Leads and/or Principle Investigators provided short presentations on behalf of their projects. Updates was provided on key ongoing initiatives in the area of AMR, with discussions on how we can better leverage/contribute to these opportunities in the coming years.